KBC Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49K | Sell |
2,411
-1,317
| -35% | -$26.8K | ﹤0.01% | 1613 |
|
|
2025
Q1 | $68K | Hold |
3,728
| – | – | ﹤0.01% | 1689 |
|
|
2024
Q4 | $94K | Buy |
3,728
+1,647
| +79% | +$41.5K | ﹤0.01% | 1598 |
|
|
2024
Q3 | $71K | Buy |
2,081
+495
| +31% | +$16.9K | ﹤0.01% | 1508 |
|
|
2024
Q2 | $59K | Hold |
1,586
| – | – | ﹤0.01% | 1517 |
|
|
2024
Q1 | $67K | Buy |
+1,586
| New | +$67K | ﹤0.01% | 1356 |
|